NCT04654676View on ClinicalTrials.gov

DPP4 Inhibitor on Glycemic Variability

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 15, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

Vildagliptin added on to stable doses of pre-mixed insulin with or without metformin

Trial Locations (1)

Unknown

Sarawak General Hospital, Kuching

All Listed Sponsors
collaborator

Sarawak General Hospital

OTHER

lead

University Malaysia Sarawak

OTHER

NCT04654676 - DPP4 Inhibitor on Glycemic Variability | Biotech Hunter | Biotech Hunter